Ionis annual meeting: all director nominees elected; equity plan increased by 4M shares

IONIS PHARMACEUTICALS INC

All four director nominees elected: Diaz (134.5M for), Hayden (133.3M), Klein (127.1M), Loscalzo (108.8M).
Say-on-pay resolution approved with 132.6M votes in favor (95.9% of votes cast).
Amendment to 2011 Equity Incentive Plan approved; authorized shares increased by 4M to 42.5M.
Ratification of Ernst & Young as 2025 independent auditors approved with 144.6M votes in favor.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.